The world of sequence variation IP is complicated and confusing, and fraught with legal risk, but there is a solution, as Ellen Sherin of GQ Life Sciences reports. The global market for bioengineered protein drugs is expected to reach $228.4 billion by 2021, up from $172.5 billion in 2016, rising at a compound annual growth…

Read More